Reduction myocardial infarct size poloxamer mannitol canine model Poloxamer thrombosis decrease whole blood viscosity perfusion tissue Mannitol free radical scavenging capabilities myocardial salvage ischemia agents different ways cardioprotective properties combination minutes left anterior coronary artery LAD occlusion dogs poloxamer mg/kg gm/kg additional minutes LAD occlusion minutes reperfusion control dogs equal volume saline solution surgery animals hours Areas myocardial infarction MI risk infarction means planimetric analysis slices myocardium triphenyltetrazolium Evans blue dye ratio MI/R mean standard error mean control mannitol Measurement microvascular blood flow similar reduction blood flow area risk treatment groups poloxamer salvage ischemic myocardium combination effective agent 